Saks, Nordstrom, Ma...
Health Care: Drugs
Geron Corporation (GERN: NASDAQ)
$1.12 0.00 | 0.00%
05/21/13 - 04:00 PM ET
Company Cash Flow
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | -68.88M | -96.85M | -111.38M | -70.18M |
| Operating Gains/Losses | -142.00K | 3.79M | 11.10M | 6.36M |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | 646.00K | 401.00K | -479.00K | -876.00K |
| (Increase) Decrease in Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | 449.00K | -482.00K | 1.29M | -56.00K |
| (Decrease) Increase In Other Current Liabilities | -1.85M | 5.71M | 6.20M | 3.90M |
| (Increase) Decrease In Other Working Capital | 3.66M | -1.01M | -741.00K | 871.00K |
| Other Non-Cash Items | 5.92M | 15.20M | 41.03M | 10.42M |
| Net Cash From Continuing Operations | -55.15M | -62.39M | -44.29M | -43.37M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | -55.15M | -62.39M | -44.29M | -43.37M |
| Sale of Property, Plant & Equipment | 170.00K | 0.00 | 2.00K | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 141.02M | 176.83M | 137.32M | 120.52M |
| Purchases of Property, Plant & Equipment | -862.00K | -612.00K | -836.00K | -1.44M |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Short-Term Investments | -79.37M | -144.89M | -183.41M | -200.11M |
| Other Cash from Investing Activities | -1.00K | 808.00K | -1.50M | 25.00K |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | 60.95M | 32.14M | -48.45M | -83.00M |
| Issuance of Debt | 0.00 | 6.42M | 0.00 | 0.00 |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 150.00K | 386.00K | 104.12M | 51.63M |
| Repayment of Long-Term Debt | 0.00 | -6.42M | 0.00 | 0.00 |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | -6.00K | 0.00 |
| Other Financing Charges, Net | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Cash From Financing Activities | 150.00K | 386.00K | 104.12M | 51.63M |
| Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash & Cash Equivalents | 5.96M | -29.87M | 11.37M | -74.75M |
Portfolios with GERN
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorBreakout Stocks Of The Week...
- Contributor22 Biopharma Stocks With Br...
- ContributorUnder-$10 Setting Up To Tra...
- ContributorStocks Under-$10 Moving Hig...
Latest GERN Headlines from TheStreet
- 8 Stocks Under $10 Soaring Higher 01.31.13 | 03:01 pm
- 5 Stocks Ready to Break Out 01.18.13 | 12:01 pm
- Stocks Slump as U.S. and Eurozone Uncertainties Fester 12.04.12 | 04:12 pm
- Stock Futures Point to Slightly Higher Wall Street Open 12.04.12 | 09:12 am
- Stocks to Watch: Oracle, Geron, Knight, Big Lots (Update 1) 12.04.12 | 07:12 am
- Morning Briefing: 10 Things You Should Know 12.04.12 | 06:12 am
- A Weak Open On Wall Street As China Stumbles 09.10.12 | 04:09 pm
- Geron's CEO Presents At Update On Imetelstat Clinical Development Program Conference (Transcript) 09.10.12 | 02:09 pm
- Geron Stung by Cancer Drug Blowup 09.10.12 | 08:09 am
- 5 Biotech Stocks Under $5 Blasting Off 08.16.12 | 03:08 pm
Press Releases for GERN
- Geron Initiates Phase 2 Trial Of GRN1005 In Brain Metastases From Breast Cancer - Business Wire 12.12.11 | 07:12 am
- Geron Presents Final Phase 1 Clinical Data On GRN1005 At AACR-NCI-EORTC - Business Wire 11.15.11 | 07:11 am
- Geron To Focus On Its Novel Cancer Programs - Business Wire 11.14.11 | 04:11 pm
- Geron Corporation Reports 2011 Third Quarter Financial Results And Events - Business Wire 11.03.11 | 04:11 pm
- Geron Announces Conference Call To Discuss Third Quarter Financial Results And Highlights - Business Wire 10.25.11 | 04:10 pm
- Geron Announces Presentation At ECTRIMS/ACTRIMS - Business Wire 10.25.11 | 07:10 am
- Geron Presents Clinical Data Update From GRNOPC1 Spinal Cord Injury Trial - Business Wire 10.20.11 | 07:10 am
- Geron Corporation Appoints John A. Scarlett As Chief Executive Officer And Director - Business Wire 09.29.11 | 05:09 pm
- Geron To Webcast Presentations At Upcoming Investor Conferences - Business Wire 09.12.11 | 07:09 am
- Geron Corporation Reports 2011 Second Quarter Financial Results And Events - Business Wire 07.28.11 | 04:07 pm
Partner Headlines for GERN
- Geron Earnings: Everything You Must Know Now - Wall St. Cheat Sheet 04.25.13 | 08:04 am
- Morning Market Losers - Benzinga 12.04.12 | 09:12 am
- Geron Posts Narrower Loss - Analyst Blog - Zacks 10.31.12 | 09:10 am
- Neuralstem Swinging For The ALS Fences - Seeking Alpha 10.29.12 | 09:10 am
- Geron Hit by Pipeline Setback - Analyst Blog - NASDAQ 09.11.12 | 09:09 pm
- Morning Market Losers - Benzinga 09.10.12 | 09:09 am
- UPDATE: Stifel Nicolaus Initiates Geron Corporation at Buy with $4 PT; Oncology Refocus Paying Off - Benzinga 08.30.12 | 12:08 pm
- Geron Posts In-Line Loss - Analyst Blog - Zacks 08.01.12 | 09:08 am
- Ford and 3 Stocks INITIATED at These Levels Today - Wall St. Cheat Sheet 06.28.12 | 03:06 am
- Medgenics Moving In Record Time - Seeking Alpha 05.21.12 | 09:05 am
